Obalon To Present at Two Upcoming Institutional Investor Conferences
November 14 2019 - 09:00AM
Obalon Therapeutics, Inc. (NASDAQ: OBLN), a weight loss
solutions company focused on commercializing the Obalon Balloon
System, the first and only FDA-approved swallowable,
gas-filled intra-gastric balloon for weight loss, announces
that Bill Plovanic, President and Chief Executive Officer, will
present corporate overviews at the following investor conferences:
Stifel 2019 Healthcare
Conference
Wednesday, November 20, 2019, Presentation time 9:10am ET
Lotte New York Palace Hotel, New York City
Webcast Available at:
http://wsw.com/webcast/stifel18/obln/
Canaccord Genuity Medical Technologies & Diagnostics
Forum
Thursday, November 21, 2019, Presentation time 2:00pm ET
The Westin Grand Central Hotel, New York City
Webcast
Available at: http://wsw.com/webcast/canaccord37/obln/
Live audio webcasts of the presentation can be accessed through
the links above. Replays of the webcasts will be available for 90
days following each presentation.
About Obalon Therapeutics, Inc. Obalon
Therapeutics, Inc. (NASDAQ:OBLN) is a San Diego-based company
focused on developing and commercializing novel technologies for
weight loss. For more information, please
visit www.obalon.com.
For Obalon Therapeutics, Inc.
Investor Contact: Bill Plovanic President & Chief Executive
Officer Obalon Therapeutics, Inc. Office: +1 760 607 5103
wplovanic@obalon.com
Obalon Therapeutics (NASDAQ:OBLN)
Historical Stock Chart
From Feb 2024 to Mar 2024
Obalon Therapeutics (NASDAQ:OBLN)
Historical Stock Chart
From Mar 2023 to Mar 2024